INTRODUCTION
Cryptosporidium species is now considered to be an important enteric protozoan pathogen, but recognition of this role evolved slowly in the 80 years since its discovery. Initially described by Tyzzer as an obscure protozoan isolated from the gastric mucosa of asymptomatic mice in 1907 (78) , Cryptosporidium species received little attention until it was suspected of causing diarrhea in turkeys in 1955 (72) . More widespread disease in animals, particularly calves and lambs, was documented with the use of improved diagnostic techniques (67, 79) . The first reported human cases in 1976 were associated with exposure to farm animals (59, 64) , and subsequent cases confirmed the classification of cryptosporidiosis as a zoonotic infection (15, 24) . In the early 1980s, most reported infections were in patients with the acquired immunodeficiency syndrome (AIDS) (34, 53, 63, 66, 75) . Those individuals had protracted, often severe, watery diarrhea and wasting, and Cryptosporidium species was considered to be primarily an opportunistic pathogen. A larger role for Cryptosporidium species in human disease has emerged with an increased awareness of the organism and readily available simplified methods of stool diagnosis (33, 37, 53) . Cryptosporidium species is now commonly identified in cases of acute, self-limited diarrheal illness in immunocompetent hosts in both developed (36, 40, 94) and developing (10, 56, 71 ; N. K. Hojlyng, K. Molbak, and S. Jepsen, Letter, Lancet i:734, 1984) nations. Travelers abroad have become infected (45, 52) , and outbreaks have occurred among children in day-care centers (1, 18, 77) . Fecal-oral spread among humans and animals and ingestion of contaminated water (26) appear to be the principal modes of transmission.
Thus, from incidental finding, veterinary disease, zoonosis, and opportunistic infection, Cryptosporidium species is now acknowledged as a cause of human diarrheal disease worldwide (30) . The intriguing discoveries of the epidemiology, pathogenesis, immunology, clinical features, and microbiology of this protozoal pathogen provide an exciting story and constitute the basis of this review.
CLASSIFICATION AND LIFE CYCLE Taxonomy. The taxonomic classification of the genus Cryptosporidium denotes its structure and basic biology (49) . Like other sporozoan parasites in the phylum Apicomplexa, Cryptosporidium species has an apical complex but no cilia or flagella. Because Cryptosporidium species has both sexual and asexual reproduction, it is placed in the class Sporozoasida. As is characteristic of other mem-* Corresponding author.
bers of the subclass Coccidiasina, Cryptosporidium species has small intracellular gametes. The development of merozoites within meronts (both type I and 11) in the process of merogony places Cryptosporidium species in the order Eucoccidiorida. Cryptosporidium, Isopora, Sarcocystis, and Toxoplasma species are members of the suborder Eimeriorina, because macrogametocytes, with a single macrogamete, and microgametocytes, which produce multiple microgametes, form independently. As a member of the family Cryptosporidiidae, the genus Cryptosporidium devel ops in a special anatomic niche, just under the surface membrane of the host cell, as an intracellular yet extracytoplasmic parasite (30, 63, 79) . Only a single host (monoxenous) is required for development of the complete life cycle of Cryptosporidium species.
Species differentiation, an area of major controversy, has been evaluated by cross-inoculation studies with organisms recovered from different hosts (80) . Cryptosporidium species has been identified in a broad range of vertebrates, including mammals, fish, birds, and reptiles. On the basis of a review of cross-transmission experiments, Tzipori et al. (80) suggested that Cryptosporidium may be a single-species genus, whereas Levine (50) has proposed four species within the genus based on host preference. Most recently, Upton and Current (20, 89) classified the species as follows: (i) C. parvum Tyzzer, 1912 , which has smaller (5.3-to 6.5-,um) oocysts, found primarily in the small intestine and responsible for most cryptosporidial diarrheal disease in humans and cattle; (ii) C. muris Tyzzer, 1907 , which has larger (6.5-to 7.9-,um) oocysts, found in gastric glands of mice and associated with a milder clinical syndrome in cattle; and (iii) C. baileyi sp. nov., with 6.2-by 4.6-,um oocysts, recently isolated from the ileum and large intestine of commercial broiler chickens (25) .
Life cycle. Upon release from ingested thick-walled oocysts, sporozoites adhere to the epithelial surface and begin development into trophozoites below the surface membrane (Fig. 1) . All other developmental stages appear to take place in the resultant parasitophorous vacuole. A characteristic dense zone of attachment to the host cell is noted by electron microscopy. During the merogony (asexual multiplication) stage of development, type I meronts produce six or eight merozoites that recycle as invasive forms after their release into the lumen of the gut. Based on structural observations in naturally infected guinea pigs, it appears that the method of reentry of merozoites into host cells is by membrane invagination (55) . In contrast to the type I meronts that enable augmented infection directly, type Il meronts produce four merozoites that differentiate separately into gametocytes. Macrogametocytes produce a single macrogamete, but microgametocytes produce about 16 microgametes. Release of microgametes enables fertiliza- tion of the single macrogametes and formation of zygotes. Subsequently, development in this sexual cycle leads to either a fragile thin-walled oocyst or, more commonly, an environmentally hardy thick-walled oocyst. The former excysts to release internally autoinfective sporozoites within the host, whereas the latter is passed outside the host. Sporozoite formation (sporogony) occurs within the original host cell in both oocyst forms before their release. This life cycle has been most consistently demonstrated in mammalian intestinal tissue, in culture in chicken chorioallantoic membranes (22) , and in several cultured cell lines (21) . The life cycle of Cryptosporidium species has been reproduced at 35, 37, and 41°C, which reflects the spectrum of temperatures found in its fish and snake, mammalian, and avian hosts (22 (10, 35, 39, 40, 56, 69) . In large prospective studies in which consecutive stool samples were examined by reliable methods, Cryptosporidium species was identified in 3 to 13% of patients with diarrhea in developing countries (Table 1) , whereas the isolation rate from matched asymptomatic controls was virtually zero. The sensitivity of different staining methods varies (33, 53) , however, and light infections may be difficult to detect. In one study from Vellore, India, where exposure begins at birth and close human contact with cattle is commonplace, Cryptosporidium species was isolated in 13.1% of individuals with diarrhea and in 9.8% of controls (57) . This observation suggests that very early and persistent exposure may be associated with asymptomatic excretion and immunity to illness.
Cryptosporidium species is rarely found in the stools of asymptomatic controls in developed countries; the prevalence was 0.1% (1 of 867) in three combined studies (6, 41, 86) . In contrast, Cryptosporidium species was found in 0.6 to 7.3% of stools from patients with diarrhea ( Table 2 ). The lowest rate was noted in Denver, Colo., in serial specimens from patients of all ages submitted to three local hospitals and to the State health department. The highest rate was noted in symptomatic children under 5 years of age in Great Transmission. Cryptosporidium species appears to be transmitted by a variety of mechanisms. Zoonotic transmission was initially considered to be the principal source of human infection for several reasons. The organism is commonly associated with diarrhea in animals, particularly calves (2, 85) , and interspecies transmission to lambs, pigs, birds, and other animals has been well documented (3, (79) (80) (81) (82) (15) were found to have high rates of excretion of Cryptosporidium species. Although calves formerly seemed to be the source of human infection by fecal-oral contamination with oocysts, other later reports have described no significant contact with farm or domestic animals in most individuals with Cryptosporidium species (39, 40, 45, 94) .
Person-to-person transmission is likely. A high prevalence in patient contacts, including exposed hospital personnel (46) and case clusters in families (19, 41, 94) , have been described. Among immunocompromised patients, most cases are described in homosexual patients with AIDS (53, 66, 68) . Cryptosporidium species was identified in 34 to 36% of children in two day-care-center outbreaks (1, 77) . Fomites may also play a role in the spread of these resistant oocysts in day-care centers.
Contaminated water has been suggested as a vehicle of infection with Cryptosporidium species in travelers to Leningrad (45) (26) . Although the organism was not recovered froin water samples in that study, oocysts were found in the secondary sewage effluent in Arizona (62) . The small size of this organisni may limit the usefulness of commonly used filters. Food-borne disease with Cryptosporidium species has not been documented.
Airborne transmission may explain the colonization of the respiratory tract in animals with Cryptosporidium species, the presence of the organism on the respiratory epithelium and in the sputum of patients with AIDS (37, 54) , and the infection of a research worker secondary to a coughing, 
PATHOGENESIS
The exact mechanism by which Cryptosporidium species causes diarrhea is not known. Bloody, inflammatory diarrhea has not been described. A secretory mechanism is consistent with large stool volumes, persistence of diarrhea after the discontinuation of oral intake, and infrequent identification of fecal leukocytes and erythrocytes (93) . Malabsorption of fat and carbohydrate may also play a role (73) , particularly in patients with AIDS (68, 93).
Infection has been described in the intestinal and respiratory tracts of poultry (28, 38) and in the gastric (7) and biliary (9) tissue of humans, and pulmonary colonization and carriage have been reported in patients with AIDS (31, 54 antibody alone may not be protective. Delineation of the surface antigens of the organism and the utilization of inbred animal models will be important advances in understanding the development of protective immunity to this parasite.
CLINICAL FEATURES Immunocompetent hosts. Now that over 600 cases of cryptosporidiosis in immunocompetent hosts have been reported, the breadth of clinical manifestations has been delineated. In most reports, the majority of cases are identified in children (40, 86) . The incubation period has been reported to range from 1 day to 2 weeks (15, 42, 43; Blagburn and Current, Letter). The infective dose required to produce infection in humans is not known. Infant macaques developed a self-limited illness when inoculated with 10 oocysts, the number found in only 0.02 ,ul of stool (6 x 105 oocysts per ml of feces) (R. A. Miller, M. A. Bronsdon, and W. R. Morton, Abstr. Annu. Meet. Am. Soc. Microbiol. 1986, B-148, p. 49). In humans, watery diarrhea is reported in 86 to 100% of index cases and 67 to 100% of infected contacts. Abdominal pain and cramping are found in over half the cases, and vomiting is also well described. Bloating and gas are less common symptoms than with G. lamblia infection, and 10 to 70% of patients experience a low-grade fever (35, 40, 43, 44, 94) . Anorexia, malaise, and weight loss may also be found in this rather nonspecific intestinal syndrome. Symptoms last for 1 to 2 weeks on the average (35, 43, 94) but may continue for more than 1 to 2 months (40, 44 (6, 69, 86, 94) . In all reported cases to date in immunocompetent hosts, the symptoms and infection ultimately resolved spontaneously. A chronic carrier state is rarely described, although very few groups have been screened and identification of low numbers of organisms may be unreliable.
Immunocompromised hosts. The clinical syndrome described in immunocompromised individuals, most of whom have AIDS, is far more virulent and persistent than that noted above. Water diarrhea of many months' duration with anorexia, abdominal pain, and weight loss is common (66, 75, 93) . Vomiting, weakness, malaise, and low-grade fever often are noted. Malabsorption (68, 93) and stool volumes of up to 8 liters/day are well documented, as are fatalities caused by dehydration and cachexia. Cough is occasionally seen in association with Cryptosporidium infection, and the organism has been identified in six immunocompromised patients with progressive pulmonary disease (31, 47, 54, 61) . Other major pathogens were found, however, in tissue sections from five of these patients. Although the data are limited, Cryptosporidium species appears to be able to colonize the lung and may be responsible for bronchitic symptoms. It appears unlikely to be a common cause of debilitating respiratory disease.
Spontaneous resolution of the infection in one child with AIDS (8), a report of asymptomatic carriage in one adult patient with AIDS (95), and our clinical experience with Cryptosporidium-infected patients with AIDS in Denver suggest that some of these individuals may tolerate their infection relatively well, either with or without drug therapy. In those with a deteriorating clinical course, attention should be focused on fluid and nutritional support.
LABORATORY DIAGNOSIS
Microscopy. Rapid and reliable techniques for the detection of Cryptosporidium species in stool provided the single most useful advance in documenting the worldwide prevalence of this infection. Before 1978, the organism was diagnosed histologically only in tissue sections and could be seen at the intestinal epithelial surface by electron microscopy or by staining with hematoxylin and eosin, Giemsa, periodic acid-Schiff, or toluidine blue. Methods for identification of Cryptosporidium species in stool samples have shown that patients with diarrhea most often excrete high numbers of oocysts, whereas asymptomatic persons with formed stools pass fewer organisms (32) . The most sensitive screening methods reported employ a murine monoclonal antibody to the oocyst wall (32, 76) . The indirect immunofluorescence method, which is not yet available commercially and which requires fluorescence microscopy, showed 100% sensitivity and specificity, even with low numbers of oocysts in the sample and without concentration (32) .
Concentration methods are recommended for identifying oocysts in the asymptomatic host and during epidemiologic or outbreak investigations (58) and may increase the diagnostic yield in the routine clinical laboratory. The Sheather sucrose flotation technique (24) has been shown to be equal to (58) or better than (53) the Formalin-ethyl acetate (ether) technique for concentrating oocysts. Aerosolization of infected material with the flotation method can be limited by the use of screw-top tubes (24). We recommend the Formalin-ethyl acetate concentration method, because it is efficient, easier and faster to perform, and better than the Sheather sucrose method for identifying G. lamblia and other protozoans (58) . The auramine O fluorescent stain may be the fastest screening procedure available (90) . Oocysts have a beaten or cratered appearance, but no internal structures are seen and morphology may be variable.
A comparison of 13 currently used staining techniques found the modified Ziehl-Neelsen hot acid-fast stain to be the best overall for sensitivity and morphology when used in conjunction with a 10% KOH initial digestion (33) . Slides can be screened under low or high dry power. With the modified acid-fast stain, the 4-to 6-,um oocysts stain bright pink-red against a green background (Fig. 2) (33) . A dimethyl sulfoxide-carbolfuchsin stain (12) and the modified Kinyoun acid-fast stain (52) eliminate the need for heat or steam and show similar staining and sensitivity. Yeasts, which are often confused with Cryptosporidium oocysts because of their size and morphology, stain green with the acid-fast procedures and brown with iodine, whereas oocysts do not stain with iodine. A Giemsa stain may show clear oocysts with pale blue internal structures but does not differentiate yeasts from oocysts. The safranin-methylene blue stain, reported to be both sensitive and rapid (10), may be visually taxing when large numbers of samples are screened. Negative stains, such as iodine, modified periodic acid-Schiff, and methenamine silver, may be less reliable than the others listed (33) . Familiarity with two staining techniques and use of control slides are advisable to assure diagnostic accuracy.
Serology. There is no commerically available assay for the serodiagnosis of Cryptosporidium infections. By indirect immunofluorescence of infected lamb mucosa, Tzipori and Campbell demonstrated antibody to Cryptosporidium species in 86% (18 of 21) of random human serum samples in Ireland and in 80 to 100% of sera from nine animal species (83) . These data suggest a high rate of human and animal exposure to this organism, but the specificity of the assay VOL. 25, 1987 (14) . In this study, low titers were found in 10 persons with no known exposure. Elevated antibody tigers followed infection and persisted for over a year. Each of five infected patients with AIDS also had detectable titers. Most 
CONCLUSIONS
Cryptosporidium species is considered a protozoan cause of diarrheal disease worldwide. The life cycle is complex. Internal autoinfection within the intestine of mammalian hosts may explain the ability of the organism to establish a significant infection despite low inoculum size (23). The diagnosis should be considered in immunocompromised hosts with persistent diarrhea, in children, particularly those involved in day-care-center outbreaks, and in individuals with exposure to animals. Travelers with diarrhea and groups involved in waterborne outbreaks of diarrheal disease should also be suspected of infection with Cryptosporidium species. Enteric precautions should be taken when in contact with infected patients, because the incidence of disease in patient contacts appears to be high. Immunocompetent hosts may have an illness that lasts 5 to 14 days and is characterized by watery diarrhea, abdominal pain, and a low-grade fever.
Oocyst excretion may persist for 1 to 2 weeks and, rarely, up to 3 months after the resolution of symptoms, so the diagnosis may be made after routine tests show negative results. Fecal leukocytes or erythrocytes or both are infrequently found. Stool diagnosis has been enhanced by the use of special stains and, in part, by concentration methods. Acid-fast and auramine stains are widely used screening procedures, and familiarity with two different methods for screening and confirmation is recommended. Yeasts can be distinguished from Cryptosporidium oocysts with iodine wet-mount and acid-fast stains.
Therapeutic options are limited but should include fluid replacement. Spiramycin, an antibiotic not approved for use in the United States, may be beneficial for control or cure of severely infected immunocompromised persons.
Noninvasive diagnostic methods have greatly enhanced our concept of the epidemiology and clinical aspects of Cryptosporidium infections. The diverse host specificity, the range of mechanisms of transmission, the variety of organs affected, and the broad range of clinical manifestations suggest that Cryptosporidium species is indeed a protean protozoan. Challenges for the future include delineating the mechanism of illness and the immunologic response to infection, as well as development of effective therapeutic agents.
